Skip to main content
. 2005 Dec 23;19(1):205–242. doi: 10.1016/j.beha.2005.04.001

Figure 6.

Figure 6

The INTERCEPT Blood System for plasma. Collected plasma is mixed with amotosalen and the mixture is placed in an ultraviolet A (UVA) illumination device. The contents are then passed through a Compound Adsorption Device (CAD) for reduction of amotosalen and free photoproducts. After CAD treatment, the plasma is placed in a final storage container until transfusion (from ref. 72).